On the other hand, induction of nuclear localization of FOXO3a and Par-4 and decreased expressions of AKT, pAKT and pFOXO3a were observed in WA-treated TRAMP tumors, confirming once again that WA inhibits AKT signaling in prostate cancer (Figure 5). This evidence concerns the gene AKT1 and prostate cancer.